Why Mustang Bio, Inc.’s (MBIO) Stock Is Down 10.99%
As of Tuesday, March 04, Mustang Bio, Inc.’s MBIO share price has dipped by 10.99%, which has investors questioning if this is right time to buy.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | MBIO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.9 | $213.9 | 3% |
|
| Shares Out (Mil) | 6.7 | 55.4 | 17% |
|
| Institutional Ownership | 99.8% | 93.3% | 94% |
|
| Float (Mil) | 6.2 | 40.6 | 14% |
|
| Beta | 2.20 | 0.98 | 94% |
|
| Avg Daily Volume (000s) | 43 | 597 | 28% |
|
| Price Change (52-week) |
(67.2%) | 40.9% | 13% |
|
| Growth | MBIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | 49.9% | (10.7%) | 94% |
|
| EPS (5yr) | 78.5% | 15.5% | 98 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (66.7%) | (15.7%) | 3% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MBIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $39 | na |
|
| Net Income (TTM) (Mil) | ($4) | ($44) | 34% |
|
| EPS (TTM) | ($0.529) | ($1.400) | 26% |
|
| Operating Cash Flow (TTM) (Mil) | ($5) | ($34) | 26% |
|
| Net Cash Flow (TTM) (Mil) | na | $-0 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($11) | $135 | 2% |
|
| Valuation | MBIO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.44 | 1.97 | 10% |
|
| P/E | na | 17.6 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.8 | na |
|
| Ratios | MBIO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.9% | na |
|
| Net Margin | na | (50.8%) | na |
|
| ROA | (20.7%) | (47.5%) | 19% |
|
| ROE | (43.1%) | (51.9%) | 17% |
|
| Liabilities to Assets | 55.1% | 29.7% | 48% |
|
| F-Score | 0 | 3 | 0% |
|
Mustang Bio, Inc. did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors